27/03/2015 13:24:57 Free Membership Login

Inovio Pharmaceuticals, Inc. News (NASDAQ:INO)

DateTimeSource
Headline
03/26/20156:01PMSEEK3 Biotechs That Could Change Medicine Forever: Wasatch Analyst Jill Wahleithner
http://seekingalpha.com/article/3032096-3-biotechs-that-could-change-medicine-forever-wasatch-analyst-jill-wahleithner?source=partner_advfn More...>>
03/19/20158:00AMGLOBEInovio Pharmaceuticals to Present at Alliance Regenerative Medicine's 2015 Regen Med Investor Day
PLYMOUTH MEETING, Pa., March 19, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that Chief Operating Officer, Dr. Niranjan Sardesai, will present at the 3rd Annual Regen Med Investor Day to be held Wednesday, March 25, 2015 at the Metropolitan Club in New York City. Dr. Sardesai's presentation... More...>>
03/18/20158:00AMGLOBEInovio Pharmaceuticals Appoints Scott M. White, M.D. Vice President, Clinical Development -- Infectious Diseases
PLYMOUTH MEETING, Pa., March 18, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today the appointment of Scott M. White, M.D. as Vice President, Clinical Development – Infectious Diseases. Dr. White will be responsible for advancing Inovio's infectious disease portfolio of DNA immunotherapies... More...>>
03/16/20152:10PMTMFWhy Inovio Pharmaceuticals Inc. Shot Higher Today
http://www.fool.com/investing/general/2015/03/16/why-inovio-pharmaceuticals-shot-higher-today.aspx?source=eptadnlnk0000002 More...>>
03/16/20158:00AMGLOBEInovio Pharmaceuticals and Academic Collaborators Receive $16 Million HIV Grant From National Institute of Allergy and Infect...
PLYMOUTH MEETING, Pa., March 16, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that the company and its academic collaborators, including the University of Pennsylvania (UPenn), were awarded a new five-year $16 million Integrated Preclinical/Clinical AIDS Vaccine Development Program... More...>>
03/16/20157:50AMSEEKInovio Pharma ups revenues 47% in Q4
http://seekingalpha.com/news/2369686-inovio-pharma-ups-revenues-47-percent-in-q4?source=partner_advfn More...>>
03/16/20156:43AMSEEKInovio Pharmaceuticals misses by $0.02, misses on revenue
http://seekingalpha.com/news/2369366-inovio-pharmaceuticals-misses-by-0_02-misses-on-revenue?source=partner_advfn More...>>
03/16/20156:30AMGLOBEInovio Pharmaceuticals Reports 2014 Fourth Quarter and Year End Financial Results
PLYMOUTH MEETING, Pa., March 16, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) today reported financial results for the fourth quarter and year ended December 31, 2014. Total revenue was $2.5 million and $10.5 million for the quarter and year ended December 31, 2014, as compared to $1.7 million and... More...>>
03/06/20158:30AMGLOBEInovio Pharmaceuticals to Report Fourth Quarter and Year End 2014 Financial Results on March 16, 2015
PLYMOUTH MEETING, Pa., March 6, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that it will host a conference call and live webcast to report its 2014 fourth quarter and year-end financial results on Monday, March 16, 2015 at 8:30 a.m. ET. A live and archived version of the audio presentation... More...>>
03/05/20158:46AMGLOBEInovio Pharmaceuticals Welcomes Nancy Wysenski to Its Board of Directors
PLYMOUTH MEETING, Pa., March 5, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO), a leader in the development of immunotherapies for cancer and infectious diseases, announced today that Nancy Wysenski joined its Board of Directors. Ms. Wysenski, a commercial pharmaceutical executive, has over 30 years... More...>>
02/03/201510:15AMBWU.S. Congressman Patrick Meehan to Present Keynote Address at 22nd Annual Groundhog Investment Forum
Congressman Meehan chaired the House Subcommittee on Cybersecurity in the 113th Congress and serves on the House Ways and Means Committee Emerald Asset Management, Inc. has announced that U.S. Congressman Patrick Meehan will present the keynote address to the close the 22nd annual Groundhog Day Investment Forum on Thursday... More...>>
02/02/20158:00AMGLOBEInovio Pharmaceuticals to Present at Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview at the 22nd Annual Emerald Groundhog Day Investment Forum on Thursday, February 5th at 2:45 PM ET. Hosted by Emerald Asset Management... More...>>
01/29/201512:05PMBWInvestment Industry to Gather in Philadelphia at 22nd Annual Groundhog Day Investment Forum
The Emerald Groundhog Day Investment Forum marks its 22nd annual event on February 5th in Philadelphia, PA with over 20 companies scheduled to present. Emerald Asset Management, Inc. will welcome hundreds of investment industry professionals to the 22nd annual Emerald Groundhog Day Investment Forum, scheduled to be held... More...>>
01/29/20158:00AMPRNUSInovio Pharmaceuticals Appoints Dr. Mark Gelder to Lead Clinical Development of Cervical Dysplasia and Cancer Programs
Inovio Pharmaceuticals Appoints Dr. Mark Gelder to Lead Clinical Development of Cervical Dysplasia and Cancer Programs Dr. Gelder's Accomplishments Include Successful Development of Cancer Therapies at Pfizer, Wyeth and Bayer PR Newswire PLYMOUTH MEETING, Pa., Jan. 29, 2015 PLYMOUTH MEETING, Pa., Jan. 29, 2015 /PRNewswire/... More...>>
01/14/20159:00AMIHNWThe Future of Cancer Science
Scientists at Propanc Health Group Corporation Pioneer New Treatment in the Fight against Metastatic Cancer   When a patient is first struck down with cancer, the first question asked is whether it has spread to other parts of the body.  Sadly, if confirmed the cancer has spread, or metastasized, it often means... More...>>
01/07/20158:00AMPRNUSInovio Pharmaceuticals' CEO to Present at 2015 Biotech Showcase Conference
Inovio Pharmaceuticals' CEO to Present at 2015 Biotech Showcase Conference PR Newswire PLYMOUTH MEETING, Pa., Jan. 7, 2015 PLYMOUTH MEETING, Pa., Jan. 7, 2015 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced that President and CEO, Dr. J. Joseph Kim, will present a company overview at the 2015 Biotech... More...>>
01/06/20158:00AMPRNUSInovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV
Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV Phase I Trial Reveals DNA Immunotherapy Results Were Similar To HIV-Infected Patients Whose Disease Did Not Progress PR Newswire PLYMOUTH MEETING, Pa., Jan. 6, 2015 PLYMOUTH MEETING, Pa., Jan. 6, 2015 /PRNewswire/ -- Inovio... More...>>
12/18/20146:00AMPRNUSInovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers
Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers Preclinical Studies Showed Tumor Shrinkage and Prevention of Tumor Recurrence PR Newswire PLYMOUTH MEETING, Pa., Dec. 18, 2014 PLYMOUTH MEETING, Pa., Dec... More...>>
12/17/20148:00AMPRNUSInovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology Dr. Yang led Janssen's prostate cancer and solid tumor therapeutic area in the U.S. PR Newswire PLYMOUTH MEETING, Pa., Dec. 17, 2014 PLYMOUTH MEETING, Pa., Dec. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO... More...>>
12/15/20148:00AMPRNUSInovio Pharmaceuticals Added to NASDAQ Biotechnology Index
Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index PR Newswire PLYMOUTH MEETING, Pa., Dec. 15, 2014 PLYMOUTH MEETING, Pa., Dec. 15, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today it has been added to the NASDAQ Biotechnology Index (NBI). The addition to the NASDAQ Biotechnology... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us amex ino150327 13:24